ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z
  • Lack of Dj-1 Amplifies Sepsis-Associated Acute Kidney Injury and Increases Parenchymal Apoptosis

    J. Leeds1, Y. Scindia2, E. Ghias1, S. Cechova1, V. Loi1, E. Mandziak1, S. Swaminathan1

  • Lack of Drug-Drug Interaction between Maribavir and Voriconazole

    I. H. Song1, K. Ilic2, J. Wu3

  • LacripepTM and its Analogs Act as Novel Interventional Agents to Promote Long-Term Islet Transplantation Outcomes

    M. Ma1, K. Teixeira2, G. Laurie2, K. Brayman1, P. Chhabra1

  • Laminin Alpha5 Regulates T Cell Entry and Distribution in Lymph Nodes in Immunity

    L. Li1, M. Shirkey1, W. Piao1, Y. Xiong1, V. Saxena1, T. Zhang1, C. Paluskievicz1, J. Zhao2, R. Abdi2, J. S. Bromberg1

  • Laparoscopic Donor Nephrectomy – Call for a Selective Radical Approach

    A. Vijay1, M. Cooper2, J. Verbesey2, P. Abrams2, S. Yi2, S. Ghasemian2

  • Large Academic Center Experience with Treatment of Suspected/Confirmed Kidney Transplant Active Antibody Mediated Rejection

    J. T. Reece1, B. A. Steiner2, V. Bhoj1, N. Aqui1, R. D. Bloom3, J. Trofe-Clark4

  • Largest Experience of Safety, and Efficacy of Patiromer in Solid Organ Transplants (SOT)

    P. Singh1, H. Winters2, T. E. Pesavento1, K. Schnelle2

  • Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

    J. Noble, F. Terrec, T. Jouve, H. Neciri Bennani, P. Benhamou, P. Malvezzi, B. Janbon, D. Giovannini, L. Rostaing

  • Late De Novo Donor Specific Antibodies in Steroid Free Immunosuppression and Delayed Graft Function

    S. Karhadkar, M. Falz, A. Diamond, A. Di Carlo, O. Timofeeva

  • Late Intra-Patient Tacrolimus Variability Predicts De Novo Donor-Specific Antibody and Graft Loss

    J. Lee1, E. Kim1, S. Yang2, S. Kim1, H. Choi3, B. Kim4, M. Ju5, M. Kim2, S. Kim2, Y. Kim2, K. Huh2

  • Late Onset Primary Graft Dysfunction after Lung Transplantation Correlates with Transplant Arteriosclerosis in a Humanized Mouse Model

    M. Franz1, T. Siemeni1, A. Knöfel1, W. Sommer1, M. Avsar1, F. Ius1, I. Tudorache1, C. Kühn1, C. S. Falk2, G. Warnecke1, A. Haverich1

  • Late Pneumocystis Jirovecii Pneumonia Often Misdiagnosed

    M. Samaniego1, R. Prashar1, N. Khoury2, A. Patel2

  • Lateral Flow Assay to Detect Soluble CD25 after Kidney Transplantation

    L. K. Seiler, C. Blume, R. Jonczyk

  • Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient with Hepatocellular Carcinoma with a GRWR of 0.35

    D. Balci1, O. Kirimker1, M. Kologlu2, U. Goktug1, E. Ustuner3, S. Karadag4, E. Er5, G. Cinar6, M. Bayar4, A. Yilmaz4, A. Azap6, K. Karayalcin1

  • Less Bleeding Associated with Apixaban versus Other Direct Acting Oral Anticoagulation in Solid Organ Transplant Recipients

    M. Thornberg1, J. Scheffert1, D. Jennings2, J. Hedvat1, N. Lange1, H. Robbins3, D. Salerno1

  • Less is More: A Single Brain Death Exam Improves Organ Donation Outcomes

    A. J. Matar1, H. Wichmann2, L. Kenney2, A. Subramanian3, J. Ratcliff4, V. Patel4, B. M. Tracy2, R. B. Gelbard2

  • Letermovir for CMV Prophylaxis and Treatment of Resistant/ Refractory CMV Disease in Solid Organ Transplant Recipients

    M. Miller1, S. Scherger2, E. Benamu2, V. Bajrovic2, P. Ramanan2, N. Madinger2, M. Barron2, S. Johnson2, T. Campbell2, A. Gray3, A. Weinberg4, M. Abidi2

  • Letermovir Treatment for Established Cytomegalovirus Infection in Transplant Recipients

    K. Linder1, C. Kovacs2, K. Mullane3, C. Wolfe4, N. Clark5, C. Butkus Small6, R. La Hoz7, J. Smith8, C. Kotton9, A. Limaye10, M. Malinis11, M. Hakki12, A. Mishkin13, A. Gonzalez14, D. Kaul1

  • Life Supporting Orthotopic Cardiac Xenotransplantation from Genetically Engineered Donor Pigs

    A. K. Singh1, C. E. Goerlich1, T. Zhang1, I. Tatarov1, P. Odonkor1, E. Strauss1, B. Williams1, B. Lewis1, A. Hershfeld1, F. Sentz1, D. Ayares2, D. Kaczorowski1, B. Griffith1, M. M. Mohiuddin1

  • Life-Supporting Pig Thymus Plus Kidney Transplantation Leads to Generation of New Baboon T-Cells and Swine-Specific Hyporesponsiveness

    Y. Okumura1, K. Takeuchi1, Y. Ariyoshi1, T. Pomposelli1, L. Boyd1, D. Alper1, K. Miyake1, K. Okubo1, S. Arn1, D. Ayares2, M. Lorber3, M. Sykes1, D. Sachs1, K. Yamada1

  • Lifetime Survival Estimates Following Solid Organ Transplantation in the United States

    C. Graham1, M. Skeans2, Y. Ahn2, C. Watson3, A. Barlev4

  • Limited Differences in Infectious Complications of Pediatric Liver Transplant between Hepatoblastoma and Non-Hepatoblastoma Patients

    H. Hendricks, A. Lane, J. Geller, A. Bondoc, A. Taylor, G. Paulsen, S. Hirth, S. Blum, G. Tiao, L. Danziger-Isakov

  • Lims1 Gene and Risk of T-Cell Mediated Rejection in Kidney Transplant Recipients

    Y. Caliskan1, G. Karahan2, S. Mirioglu3, Y. Ozluk4, R. Ouseph1, H. Yazici3, H. Randall5, F. Savran Oguz6, A. Turkmen3, M. S. Sever3, K. Lentine1

  • Live Donor Liver Transplant Offers Higher Survival, Improved Quality of Liver and Lower Morbidity for Recipients with Low MELD Score

    M. Black, J. Bayer, H. Fernandez, E. Martinez, G. McKenna, N. Onaca, R. Ruiz, G. Testa, A. Wall, T. Ma, G. Saracino, S. Asrani, A. Gupta

  • Liver Biopsy Does Not Change Transplant Candidacy Decisions for Hepatitis B Virus Positive Living Donor Kidney Transplant Recipients

    C. Baek, H. Kim, S. Park

  • Liver Live Donor Champion: Advocacy Training to Facilitate Identification of Live Liver Donors

    A. D. Love1, L. R. Herbst1, D. R. Helfer1, L. Kurman2, M. G. Bowring1, S. R. Weeks1, E. King1, D. L. Segev1, J. Garonzik Wang1

  • Liver Plasmacytoid Dendritic Cells Express High Levels of DAP12, TREM2 and PD-L1 and Promote Effector T Cell Exhaustion and Augmented Treg Responses in Spontaneous Liver Transplant Tolerance

    R. Nakano, O. Yoshida, S. Kimura, D. Geller, A. Thomson

  • Liver Retransplantation (reLT) in the Modern Post-MELD, Post-DAA Era

    B. Shi, C. Freise, D. Brandman

  • Liver Transplant Outcomes Across the Age Distribution and Interactions with County Health

    S. K. Niazi1, E. Vargas2, A. Spaulding3, J. Crook2, T. Schneekloth4, A. Keaveny5, A. Vasquez6, M. Gentry4, T. Rummans6, C. Taner5

  • Liver Transplant Outcomes in Deceased Donors with Elevated Bilirubin: A Large Database Analysis

    P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, J. Glorioso, C. Ramirez, H. Dang, A. S. Bodzin

  • Liver Transplant Outcomes in Menopausal Women During the Meld Era

    C. Brady1, A. Parish2, D. Niedzwiecki2

  • Liver Transplant Recipients with BMI 40 to <50 kg/m2 Have Excellent Patient and Graft Survival

    K. Daniel, J. Hause, F. Osman, J. Mezrich, E. Spengler

  • Liver Transplant Recipients with High DSA at Time of Transplant Do Not Have Increased Rejection or Mortality

    A. Demirag1, B. Rawashdeh1, S. L. Lennon1, S. Pelletier1, J. Iezzoni2, K. Khutsisvhili3, S. Shumilina1, K. Chittum1, J. Oberholzer1, P. Lobo4

  • Liver Transplant Waitlist Mortality is Not Associated with Urbanicity

    Y. Chen1, Y. Hung2, Y. Hsu3, C. de Crescenzo1, C. Rickert1, J. Adler4, D. Chang1, H. Yeh1

  • Liver Transplant with Donation after Cardiac Death versus Donation after Brain Death Donors: Survival and Outcomes at 10 Years

    O. Haque1, E. Roth2, A. Fleishman1, K. Khwaja1

  • Liver Transplantation as a Salvage and Uncommon Procedure for a Patient with Colorectal Liver Metastsis with Promising Results, Case Presentation and Literature Review

    M. Tabbal, M. Al Qahtani

  • Liver Transplantation for Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Survival Rates

    I. A. Ziogas1, K. P. Economopoulos2, M. H. Hayat1, L. K. Matsuoka1, M. I. Montenovo1, M. Izzy1, S. P. Alexopoulos1

  • Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience

    S. Hassan1, K. Mysore1, D. N. Cerminara2, K. E. Hosek3, M. Faraone4, R. Sigereddi5, R. Ackah5, A. Rana6, J. Goss6, T. Galvan6

  • Liver Transplantation for Primary Liver Sarcoma in Children-The US Experience from the Scientific Registry for Transplant Recipients (1988-2018)

    A. Amin, K. Soltys, S. Ranganathan, G. Bond, A. Khanna, A. Ganoza, Q. Sun, G. Mazariegos, R. Sindhi

  • Liver Transplantation from Donors after Circulatory Death Using “tPA”Protocol: The University of Miami Experience

    R. Vianna, A. Farag, G. Selvaggi, A. Tekin, W. De Faria, M. Morsi, R. Miyashiro, T. Beduschi

  • Liver Transplantation in Locally Unresectable, Undifferentiated Embryonal Cell Sarcoma

    B. I. Babu, D. L. Bigam, K. Z. Dajani, J. A. Shapiro, N. Kneteman

  • Liver Transplantation in Obese Recipients: Post-Transplant Weight Gain and Outcomes

    D. Soma1, Y. Park1, P. Mihaylov1, B. Ekser1, M. S. Ghabril2, M. A. Lacerda2, N. Chalasani2, R. S. Mangus1, C. A. Kubal1

  • Liver Transplantation in Patients Requiring Pre-Transplant Mechanical Ventilation

    T. Ito, A. Aziz, A. E. Murray, S. Younan, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Liver Transplantation of Donors and Recipients’ with Situs Inversus Totalis: Case Reports and Literature Review

    L. Del Angel Diaz, A. Simioni, G. D'Amico, Q. Liu, K. Hashimoto, M. Fujiki, B. Eghtesad, F. Aucejo, K. Sasaki, C. Kwon, C. Miller, C. Quintini, T. Diago-Uso

  • Liver Transplantation of Hepatitis C Viremic Donors to Hepatitis C Naive Recipients

    R. K. Gilroy, F. Lopez-Verdugo, G. Harmston, S. Fujita, M. E. Boschert, I. Zendejas, E. J. Frech, A. Gagnon, R. Jones, J. Krong, S. Sell, S. Dow, L. Lindberg, M. Rodriguez-Davalos, D. Alonso

  • Liver Transplantation with Grafts from Super Obese Donors with a BMI>50

    P. Vargas1, J. M. Cullen1, P. Northup2, J. Oberholzer1, S. Pelletier1, N. Goldaracena1

  • Livers from Donation after Cardiac Death (DCD) Offer – Accept or Decline?

    T. Ishaque, M. G. Bowring, J. D. Motter, Y. Yu, S. Yu, A. B. Kernodle, J. G. Wang, S. Getsin, D. L. Segev, A. B. Massie

  • Living Donor Gender Disparities Vary by Donor-Recipient Familial Relationship

    Y. Chen1, Y. Hung2, C. de Crescenzo1, C. Rickert1, Y. Hsu3, H. Yeh1, D. Chang1

  • Living Donor Liver Transplantation Demonstrated Superiority to Deceased Donor Transplantation after Adult-To-Adult Liver Transplantation in Cumulative Single-Center Retrospective Cohort Study of 19 Years

    T. Goto, T. Reichman, G. Sapisochin, I. McGilvray, M. Selzner, A. Ghanekar, M. Cattral, N. Selzner

  • Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond UCSF Criteria: Tumor Biology Not the Tumor Number Decide the Long Term Outcome- A Single Center Retrospective Analysis of Using Extended Criteria

    A. Thorat, L. Jeng, S. Hsu, H. Yang, P. Li, T. Chen, K. Poon

  • Living Donor Liver Transplantation for Unresectable Liver Confined Colorectal Liver Metastases: A North American Experience

    L. I. Ruffolo, K. Dokus, M. Larye, J. Errigo, J. Bhoely, R. Dunne, M. Levstik, B. Al-Jadaibi, K. Tomiyama, R. Hernandez-Alejandro

  • Living Donor Liver Transplantation Should Be Considered Cautiously in Recurrent Hepatocellular Carcinoma within the Milan Criteria after Curative Liver Resection

    J. Kim1, N. Yi2, G. Choi1, C. D. Kwon3, K. Lee2, K. Suh2, J. Joh1

  • Living Donor Nephrectomy Outcomes in the Us: Analysis of HCUP Data

    M. S. Gharibdousti1, M. T. Khasawneh2, A. L. Friedman3

  • Living Donor versus Deceased Donor Liver Transplantation in USA: Where Do We Stand, Where to Go

    A. M. Elsabbagh1, A. Yoshida1, J. Fung2, M. Abouljoud1

  • Living Kidney Donation is Associated with Accelerated Podocyte Loss Early after Donation

    A. S. Naik, D. Le, S. Wang, M. Chowdhury, M. D. Doshi, R. Wiggins

  • Living Kidney Donor Assessment: Kidney Length versus Differential Function

    K. J. Schumacher, J. A. Akoh

  • Living Kidney Donor Profile Index Used to Assess Donor Risk Factors Affecting the Survival Rate of Transplanted Kidney and Comparison with Kidney Donor Profile Index of Deceased Donor Kidney Transplantation

    S. Kang1, M. Kang2, R. Ra1, J. Kong2, J. Kim2, H. Hwang2, K. Jeong2

  • Living Liver Donation in Previous Kidney Donors – A Valuable Resource for Hepatic Allografts without Compromising Donor Safety

    A. Nair, K. Sasaki, T. Diago Uso, M. Fujiki, B. Eghtesad, D. Kwon, F. Aucejo, C. Quintini, C. Miller, K. Hashimoto

  • Living versus Deceased Donor Liver Transplantation in Cholestatic Liver Disease: An Analysis of the OPTN Database

    I. A. Ziogas1, S. P. Alexopoulos1, L. K. Matsuoka1, S. K. Geevarghese1, L. D. Gorden1, S. J. Karp1, J. D. Perkins2, M. I. Montenovo1

  • Long Term Effect of Tacrolimus Conversion to Sirolimus with Prednisone-Free Regimen in Kidney Allograft Outcomes: A Dynamic Analysis of Graft Survival Using Joint Modeling

    S. H. Park1, B. Ho1, K. Guo1, L. Zhao2, V. Mas3, J. Leventhal4, L. Gallon1

  • Long Term Graft Outcome after Subclinical Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection

    A. Han, H. Ko, C. Chung, H. Kim, S. Min, J. Ha

  • Long Term Liver Transplant Survivors

    M. Haberal1, E. Ayvazoglu Soy1, G. Moray1, F. Ozcay2, A. Torgay3

  • Long Term Outcome of Patients Transplanted for Non Alcoholic Steatohepatitis Related Cirrhosis

    W. Alhamoudi1, I. Salih2, S. Yousif2, M. Shawkat3, K. Bzeizi2, S. Alghamdi2, A. Albenmousa2, D. Broering2

  • Long Term Outcomes Following Uncontrolled and Controlled Donation after Cardiac Death Liver Transplantation in the United States

    R. A. Choudhury1, D. Yoeli1, H. Yaffe1, H. B. Moore1, G. Hoeltzel2, A. Schulick1, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

  • Long Term Outcomes of Hypertensive Kidney Donors

    H. Ibrahim, S. Hebert, H. E. Adrogue, D. T. Nguyen, E. A. Graviss, A. Gaber, A. Matas

  • Long Term Outcomes of Kidney Transplantation in Patients with AL-Amyloidosis – The Mayo Clinic Experience

    A. Bentall1, C. Heybali2, J. Wen3, A. Hatem1, C. A. Schinstock1, E. Lorenz1, M. El Ters1, M. Mai4, H. Khamash5, D. Murray6, M. D. Stegall7, F. G. Cosio1, M. P. Alexander6, N. Leung1

  • Long Term Ursodeoxycholic Acid Use Does Not Alter Long Term Rejection, Biliary Complication, Mortality or Hospitalization Rates after Liver Transplantation

    T. Ashraf1, V. Mendiratta2, S. Gill1, A. Abdelwahab3, D. Moonka2, S. Jafri2

  • Long Term Vasculobiliary Problems Associated with Hepatic Artery Stenosis Following Liver Transplant

    R. Seth, T. Perera

  • Long-Term Allograft Survival via Donor MHC Chimerism Induced by Exosomes

    B. Gonzalez Nolasco, X. Wang, M. Wang, A. Prunevieille, K. M. Lee, J. F. Markmann, G. Benichou

  • Long-Term Effect of Kidney Transplantation on Peripheral Arterial Disease

    C. Choi1, M. Ahn1, S. Kim1, A. Han2, H. Ohe3, S. Min2, S. Ahn2, S. Min2, J. Ha2

  • Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

    J. Leventhal1, J. Mathew1, J. Galvin2, L. Gallon1, D. Belshe1, K. Ravindra3, M. Horwitz3, J. Miller1, S. Ildstad4

  • Long-term Functional Survival of Human Stem Cell-Derived Islets Microencapsulated in Alginate with CXCL12 in Non-Human Primates without Immunosuppression

    M. C. Poznansky1, D. Alagpulinsa1, J. Lei2, R. Pop3, D. Sobell4, M. Chapin1, S. Collins3, A. Veres3, H. Deng2, D. Melton3, J. Markmann2

  • Long-Term Islet Allo- and Xenograft Survival is Promoted by Immunoglobulin M Immunotherapy

    M. Ma, K. Brayman, P. Chhabra

  • Long-Term Kidney Graft Survival is Superior with Simultaneous-Liver Kidney (SLK) Transplants Than Kidney Alone (KA) or Kidney after Liver (KALi) Transplants in the United States

    N. Lim1, S. M. Riad1, S. Jackson2, J. Lake1

  • Long-Term Liver Transplant Outcomes: A Single Center Cohort Study

    S. A. Mao, K. P. Croome, I. J. Galler, C. B. Taner

  • Long-Term Metabolic Control and Health Outcomes in Maple Syrup Urine Disease Following Liver Transplantation in Children and Young Adults

    C. Ewing1, K. Soltys2, K. Strauss3, G. Mazariegos2, R. Sindhi2, J. Vockley2, P. McKiernan2, R. Squires2, G. Bond2, A. Khanna2, J. Squires2

  • Long-Term Outcome of Kidney Transplantation for IgA Nephropathy: A Single-Center Experiences

    M. Tasaki1, K. Saito1, Y. Nakagawa2, N. Imai3, Y. Ito3, K. Takahashi4, Y. Tomita1

  • Long-Term Outcomes for Living Kidney Donors: A Japanese Single-Center Experience

    K. Hotta, D. Iwami, N. Iwahara, N. Shinohara

  • Long-Term Outcomes for the Use of Native Small Capacity, Defunctionalized Bladders in Pediatric Kidney Transplantation

    P. Vuong, A. Brubaker, L. Maestretti, W. Concepcion, A. Gallo

  • Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension

    F. Al Ammary1, S. Yu2, A. Muzaale2, L. Luckmini2, D. C. Crews1, D. Brennan1, D. Segev2, A. B. Massie2

  • Long-Term Outcomes of Kidney Donors with Nephrolithiasis

    M. R. D'Costa, M. A. Merzkani, A. Denic, A. F. Mullan, J. J. Larson, W. K. Kremers, W. D. Park, M. P. Alexander, S. J. Taler, N. S. Issa, M. D. Stegall, A. D. Rule

  • Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study

    S. Prockop1, R. Reshaf2, D. Tsai3, N. Bunin4, R. Abu-Arja5, K. Mahadeo6, W. Weng7, K. Van Besien8, D. Loeb9, S. Dwivedy Nasta10, E. Nemecek11, M. Hiremath12, S. Yue12, Y. Sun12, W. Navarro12, S. Nikiforow13

  • Long-Term Outcomes of Single Kidney Transplants from Small Pediatric Donors

    S. Sultan, J. Son, M. Aull, R. Craig-Schapiro, A. Watkins, S. Kapur

  • Long-Term Outcomes of Stone Former Donors at the University of Minnesota

    A. Khan1, S. M. Riad1, D. Keys1, S. Jackson1, A. Matas2

  • Long-Term Outcomes with Islet Alone and Islet-after-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium

    M. R. Rickels1, T. L. Eggerman2, L. Bayman3, J. C. Qidwai3, R. Alejandro4, N. D. Bridges5, B. J. Hering6, J. F. Markmann7, P. A. Senior8, L. G. Hunsicker3

  • Long-Term Pediatric Outcomes of Simultaneous vs. Sequential Liver-Kidney Transplantation: A Review of the UNOS Database

    K. Goli1, A. Rana1, J. Goss1, T. Miloh2

  • Long-Term Safety in Epstein-Barr Virus (EBV)-Seropositive Kidney-Only Transplant Recipients Treated with Belatacept (BELA) in Clinical Practice: Final Study Results from the ENLiST Registry

    C. Larsen1, F. Vincenti2, T. Kou3, C. Shadur4, B. Bresnahan5, S. Jordan6, E. S. Woodle7, N. Goes8, J. Vella9, D. Wojciechowski10, M. Polinsky3, A. Gomez-Caminero3

  • Longer-Term Outcomes from the THINKER and EXPANDER Trials of Transplantation Using HCV-Viremic Kidneys

    V. S. Potluri1, F. Naqvi2, P. Reese1, M. Shah1, D. Brown2, S. Prenner1, A. Loupy3, A. Woodards1, P. Abt1, E. Blumberg1, J. Trofe-Clark1, D. Segev2, R. Bloom1, D. Sawinski1, C. Durand2, P. Porrett1, M. Levine1, D. Goldberg4, N. Desai2

  • Longitudinal Study Investigating Characteristics of Human Polyimaviruses Infection after Kidney Transplantation

    E. Favi1, S. Delbue2, C. Colico1, L. Signorini2, L. Clementoni1, M. Ferraresso1

  • Lose Weight to Donate Program: Preliminary Results of a Program Intended to Optimize Obese Living Donor Liver Candidates

    J. Rose1, T. Seay2, A. Pesch3, P. Vargas4, S. Pelletier4, J. Oberholzer4, C. Argo5, N. Goldaracena4

  • Lost to Follow-Up in Kidney Transplant Recipients – A QI Project

    M. R. D'Costa, H. S. Ohl, S. Iyengar, K. C. Kolbet, C. L. Williams, K. A. Larson, M. S. Ward, H. M. Shriver, W. K. Kremers, M. El Ters

  • Low Diagnostic Yield of Protocol Allograft Biopsy Performed During DGF in Deceased Donor Kidney Transplant Recipients Treated with Induction and Standard-Dose CNI-Based Maintenance

    E. Favi1, A. James2, M. Ferraresso1, R. Cacciola3

  • Low Food Security in Inner-City Kidney Transplant Recipients is Associated with Worse Graft Function, Lower Fruit and Vegetable Intake and Increased Psychosocial Stress

    E. Kasparov, K. Cruickshank, A. Saleh, S. Pak, M. Markell

  • Low HLA Class I Epitope Mismatch Associated with Improved Pancreas Graft Survival in Simultaneous Pancreas-Kidney Transplantation

    J. M. Ladowski, M. Romine, D. Kloda, C. Young, J. Locke, V. Hauptfeld-Dolejsek, J. Houp

  • Low Level CMV Detection and Effectiveness of Low Dose Valganciclovir Prophylaxis in Intermediate-Risk Liver Transplant Recipients

    A. Nolan1, B. Lovett2, B. Lindner1, J. G. Timpone3

  • Low Mycophenolic Acid Levels are Associated with More Inflammation on 1 Year Protocol Biopsies and Lower Graft Survival in Kidney Transplant Recipients

    J. Huskey, G. Mour, M. Ryan, S. Nair, M. Smith, R. Heilman

  • Low Physiochemical Immunogenicity Scores Improve Long-Term Survival of Deceased Donor Kidney Transplants

    D. Bekbolsynov1, B. Mierzejewska1, J. Borucka2, S. A. Khuder1, M. Rees1, R. Green3, S. Stanislaw1

  • Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection

    E. Sartain1, B. Nettles1, B. Crowther1, P. Klem1, K. Schwarz1, S. Davis2

  • Lower Extremity Vascular Complications after Simultaneous Pancreas Kidney Transplant

    H. J. Braun, D. Amara, T. Sorrentino, J. L. Ramirez, J. Lin, A. Mello, P. G. Stock, J. S. Hiramoto

  • Lowering Meld, Diminishing Length of Stay, and Increasing Liver Transplant Numbers Comes Through the Generosity of Others: Declined HCV-NAT Offers Subsequently Transplanted Have Excellent Outcomes

    R. Gilroy, S. Sell, J. Krong, A. Gagnon, I. Zendejas, S. Fujita, M. Rodriguez, D. Alonso

  • Lung Mucosal Biopsies Deteriorate with Time Post-Transplant: A Molecular Analysis

    M. D. Parkes1, P. Halloran1, K. Halloran2, &. the INTERLUNG Study Group3

  • Lung Transplantation for Patients with Pneumoconiosis in China: A Multicenter Experience from 2015-2019

    J. Zhang1, D. Liu1, W. Han2, J. Chen1

  • Lymph Node Stromal Laminin Alpha5 Regulates Antigen Specific T Cell Adaptive Immunity

    L. Li1, M. Shirkey1, W. Piao1, Y. Xiong1, V. Saxena1, T. Zhang1, C. Paluskievicz1, J. Zhao2, R. Abdi2, J. S. Bromberg1

  • Lymphoceles in Kidney Transplant Recipients: Incidence, Risk Factors, Outcomes, and Clinical Management

    J. Kim, E. Nguyen, M. Minkovich, O. Famure, Y. Li, J. Lee

  • Lymphotoxin Beta Receptor Regulates Draining Lymph Node Structure and Treg Migration

    V. Saxena1, W. Piao1, L. Li1, Y. Xiong1, C. C. Palusckievicz1, T. Simon1, M. W. Shirkey1, R. Abdi2, J. S. Bromberg1

  • Lymphycyte Subset Test as a Determinant of Cytomegalovirus Prophylaxis in Renal Transplant Recipients

    M. Kim, Y. Park, S. Mok, K. Jun, S. Kim, J. Kim, S. Yun, I. Moon, S. Park

Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences